Home
John Lunger, Chief Patient Supply Officer: Adaptimmune Therapeutics ADAPY Sell · Filed 25/01/17
Trade details
- Type
- Insider sale
- Amount
- $3,238.72
- Shares · price
- 5,584 sh · $0.58 a share
- Held after
- 7,510 sh
- Trade date
- 25/01/17
- Filed
- 25/01/17
- Days to filing
- 0 days
Sold 42.6% of holdings
- Share of holding sold
- 42.6%
Adaptimmune Therapeutics trades, last 26 weeks
What else happened in Adaptimmune Therapeutics around then
Filed or reported within 30 days of the trade day · 24/12/18~25/02/16John Lunger's recent trades
- John Lunger
Planned saleAdaptimmune Therapeutics
Planned saleAdaptimmune Therapeutics
ADAPY
$3,243
5,584 sh
$3,243
Filed 25/01/17
Traded 25/01/17
- John Lunger
SellAdaptimmune Therapeutics
SellAdaptimmune Therapeutics
ADAPY
$5,588
9,803 sh
$5,588
Filed 25/01/15
Traded 25/01/15
- John Lunger
SellAdaptimmune Therapeutics
SellAdaptimmune Therapeutics
ADAPY
$3,228
5,471 sh
$3,228
Filed 25/01/15
Traded 25/01/13
- John Lunger
SellAdaptimmune Therapeutics
SellAdaptimmune Therapeutics
ADAPY
$2,518
4,268 sh
$2,518
Filed 25/01/15
Traded 25/01/13
- John Lunger
Planned saleAdaptimmune Therapeutics
Planned saleAdaptimmune Therapeutics
ADAPY
$5,726
9,739 sh
$5,726
Filed 25/01/15
Traded 25/01/13